Blüthner M, Bautz E K, Bautz F A
Institute of Molecular Genetics, University of Heidelberg, Germany.
J Immunol Methods. 1996 Nov 13;198(2):187-98. doi: 10.1016/s0022-1759(96)00160-3.
Sera from patients suffering from the polymyositis/scleroderma overlap syndrome (PM/Scl) recognize two antigenically non-related proteins with apparent molecular masses of 100 kDa and 75 kDa respectively. The two proteins are part of a particle termed PM/Scl localized in the granular component of the nucleolus. The predominant immunoreactivity of the PM/Scl sera was shown to be directed against the 100 kDa protein. The cDNA of the 100 kDa protein has been cloned recently and its immunogenic regions have been partially mapped using recombinant proteins. Thus far the localization of antigenic determinants on polypeptides has been done by expressing defined cDNA fragments in bacteria or by synthesizing overlapping short peptides and probing their immunoreactivity with antibodies. Here we present an alternative approach to localize autoimmune epitopes using sera containing polyclonal antibodies and gene-fragment phage display libraries. For epitope fine mapping of the PM/Scl-100 protein random fragments of the corresponding cDNA were cloned into the PIII protein of fUSE-5. These gene-fragment phage display libraries were incubated with affinity purified anti-PM/Scl-100 antibodies to enrich for epitope-displaying phages. All PM/Scl sera tested recognized 23 consecutive amino acids (229-251) encoded by four overlapping fUSE-5 clones, suggesting that a major epitope is contained within the 23 amino acids. In addition a minor epitope was localized in a region of 21 amino acids (775-795) encoded by two overlapping fUSE-5 clones since only three out of the seventeen sera reacted with this amino acid sequence. Additional fine mapping of the major epitope was done using synthetic oligopeptides. Thus, a stretch of 16 amino acids at position 229-244 could be identified as a major epitope on the deduced PM/Scl-100 amino acid sequence.
患有多肌炎/硬皮病重叠综合征(PM/Scl)的患者血清可识别两种抗原性不相关的蛋白质,其表观分子量分别为100 kDa和75 kDa。这两种蛋白质是一种称为PM/Scl的颗粒的一部分,该颗粒位于核仁的颗粒成分中。已证明PM/Scl血清的主要免疫反应性针对100 kDa的蛋白质。100 kDa蛋白质的cDNA最近已被克隆,其免疫原性区域已使用重组蛋白进行了部分定位。到目前为止,多肽上抗原决定簇的定位是通过在细菌中表达特定的cDNA片段或通过合成重叠的短肽并用抗体检测其免疫反应性来完成的。在这里,我们提出了一种使用含有多克隆抗体的血清和基因片段噬菌体展示文库来定位自身免疫表位的替代方法。为了对PM/Scl-100蛋白进行表位精细定位,将相应cDNA的随机片段克隆到fUSE-5的PIII蛋白中。将这些基因片段噬菌体展示文库与亲和纯化的抗PM/Scl-100抗体孵育,以富集展示表位的噬菌体。所有测试的PM/Scl血清都识别由四个重叠的fUSE-5克隆编码的23个连续氨基酸(229-251),这表明主要表位包含在这23个氨基酸内。此外,一个次要表位位于由两个重叠的fUSE-5克隆编码的21个氨基酸区域(775-795),因为在17份血清中只有3份与该氨基酸序列反应。使用合成寡肽对主要表位进行了进一步的精细定位。因此,在推导的PM/Scl-100氨基酸序列上,229-244位的一段16个氨基酸可被确定为主要表位。